301 related articles for article (PubMed ID: 24267302)
21. Systemic fat embolism and pulmonary hypertension in sickle cell disease.
Castro O
Hematol Oncol Clin North Am; 1996 Dec; 10(6):1289-303. PubMed ID: 8956017
[TBL] [Abstract][Full Text] [Related]
22. [Pulmonary arterial hypertension and sickle cell disease].
Savale L; Maitre B; Bachir D; Galactéros F; Simonneau G; Parent F
Presse Med; 2013 Mar; 42(3):338-46. PubMed ID: 22743045
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked.
Farmakis D; Aessopos A
Circulation; 2011 Mar; 123(11):1227-32. PubMed ID: 21422398
[No Abstract] [Full Text] [Related]
24. Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection.
Barnett CF; Hsue PY; Machado RF
JAMA; 2008 Jan; 299(3):324-31. PubMed ID: 18212317
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary hypertension in sickle cell disease.
Vichinsky EP
N Engl J Med; 2004 Feb; 350(9):857-9. PubMed ID: 14985481
[No Abstract] [Full Text] [Related]
26. A hemodynamic study of pulmonary hypertension in sickle cell disease.
Parent F; Bachir D; Inamo J; Lionnet F; Driss F; Loko G; Habibi A; Bennani S; Savale L; Adnot S; Maitre B; Yaïci A; Hajji L; O'Callaghan DS; Clerson P; Girot R; Galacteros F; Simonneau G
N Engl J Med; 2011 Jul; 365(1):44-53. PubMed ID: 21732836
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary hypertension in sickle cell disease: diagnosis and management.
Ataga KI; Klings ES
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):425-31. PubMed ID: 25696889
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary hypertension in sickle cell disease.
Ataga KI; Sood N; De Gent G; Kelly E; Henderson AG; Jones S; Strayhorn D; Lail A; Lieff S; Orringer EP
Am J Med; 2004 Nov; 117(9):665-9. PubMed ID: 15501204
[TBL] [Abstract][Full Text] [Related]
29. Sickle-cell anemia and pulmonary hypertension.
Ninkovich GM; Miller SK; Alpert PT
J Am Acad Nurse Pract; 2010 Apr; 22(4):198-204. PubMed ID: 20409257
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease.
Gladwin MT
Expert Rev Hematol; 2011 Dec; 4(6):593-6. PubMed ID: 22077523
[No Abstract] [Full Text] [Related]
31. Symptomatic pulmonary hypertension in a child with sickle cell disease.
Villavicencio K; Ivy D; Cole L; Nuss R
J Pediatr; 2008 Jun; 152(6):879-81. PubMed ID: 18492535
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience.
Mahesh B; Besser M; Ravaglioli A; Pepke-Zaba J; Martinez G; Klein A; Ng C; Tsui S; Dunning J; Jenkins DP
Eur J Cardiothorac Surg; 2016 Sep; 50(3):537-41. PubMed ID: 26987879
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary hypertension and NO in sickle cell.
Gladwin MT; Barst RJ; Castro OL; Gordeuk VR; Hillery CA; Kato GJ; Kim-Shapiro DB; Machado R; Morris CR; Steinberg MH; Vichinsky EP
Blood; 2010 Aug; 116(5):852-4. PubMed ID: 20688967
[No Abstract] [Full Text] [Related]
34. Fatal hemolytic anemia presumably due to the combination of sickle cell and thalassemia gene; case report.
NAIL SK; KOTHARI BV; JHAVERI CL; SUKUMARAN PK; SANGHVI LD
Indian J Med Sci; 1957 Apr; 11(4):244-9. PubMed ID: 13428325
[No Abstract] [Full Text] [Related]
35. Pulmonary hypertension in sickle cell disease.
Lee MT; Rosenzweig EB; Cairo MS
Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies.
Collins FS; Orringer EP
Am J Med; 1982 Dec; 73(6):814-21. PubMed ID: 7148875
[TBL] [Abstract][Full Text] [Related]
37. Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.
Phrommintikul A; Sukonthasarn A; Kanjanavanit R; Nawarawong W
Heart; 2006 Oct; 92(10):1467-72. PubMed ID: 16621878
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms.
Ferrari A; Scandura J; Masciulli A; Krichevsky S; Gavazzi A; Barbui T
Eur J Haematol; 2021 Feb; 106(2):250-259. PubMed ID: 33135220
[TBL] [Abstract][Full Text] [Related]
39. Primary pulmonary hypertension. Its association with microangiopathic hemolytic anemia and thrombocytopenia.
Jubelirer SJ
Arch Intern Med; 1991 Jun; 151(6):1221-3. PubMed ID: 2043024
[TBL] [Abstract][Full Text] [Related]
40. World Health Organization group 5 pulmonary hypertension.
Lahm T; Chakinala MM
Clin Chest Med; 2013 Dec; 34(4):753-78. PubMed ID: 24267303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
